BAILARD, INC. - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 168 filers reported holding ACCELERON PHARMA INC in Q2 2019. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$344,000
+37.1%
2,0000.0%0.01%
+33.3%
Q2 2021$251,000
-36.1%
2,000
-31.0%
0.01%
-40.0%
Q1 2021$393,000
+5.9%
2,9000.0%0.02%
-11.8%
Q4 2020$371,000
-45.0%
2,900
-51.7%
0.02%
-51.4%
Q3 2020$675,000
+1.2%
6,000
-14.3%
0.04%
-5.4%
Q2 2020$667,000
+6.0%
7,0000.0%0.04%
-17.8%
Q1 2020$629,000
+48.3%
7,000
-12.5%
0.04%
+87.5%
Q4 2019$424,000
-17.5%
8,000
-38.5%
0.02%
-22.6%
Q3 2019$514,000
-3.7%
13,0000.0%0.03%
-6.1%
Q2 2019$534,000
+10.3%
13,000
+25.0%
0.03%
+10.0%
Q1 2019$484,000
+6.8%
10,4000.0%0.03%
-3.2%
Q4 2018$453,000
-40.0%
10,400
-21.2%
0.03%
-29.5%
Q3 2018$755,000
+15.3%
13,200
-2.2%
0.04%
+12.8%
Q2 2018$655,000
+59.4%
13,500
+28.6%
0.04%
+50.0%
Q1 2018$411,000
+20.9%
10,500
+31.2%
0.03%
+23.8%
Q4 2017$340,0008,0000.02%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Artal Group S.A. 1,400,000$133,378,0003.73%
Foresite Capital Management III, LLC 42,030$4,004,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 257,249$24,508,0002.23%
Cormorant Asset Management, LP 600,000$57,162,0002.18%
Avoro Capital Advisors LLC 1,040,000$99,081,0001.96%
QVT Financial LP 101,396$9,660,0001.64%
FARALLON CAPITAL MANAGEMENT LLC 2,100,000$200,067,0001.60%
Rhenman & Partners Asset Management AB 155,000$14,767,0001.60%
Parkman Healthcare Partners LLC 57,500$5,478,0001.54%
Ikarian Capital, LLC 187,700$17,882,0001.42%
View complete list of ACCELERON PHARMA INC shareholders